← Back to Analyst Consensus 
LKFT Hold
Lakefront Biotherapeutics NV
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 23, 2026 | RBC Capital | upgrade | Sector Perform → Outperform | — | 55% |
| Aug 11, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Aug 11, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
| Feb 25, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
Price Target Trend
May 13, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days